Kevin F Mclaughlin
Director at VCEL; SVP, CFO and Treasurer at ACCELERON PHARMA INC
Filed with the SEC as MCLAUGHLIN KEVIN F
- Sold, on record
- $32M
- Dollars the filings state
- Form 4 sales
- 49
- Latest Nov 10, 2026
- Form 144 notices
- 10
- Proposed sales
- Quarters with a sale
- 8 of the last 8
- 8 days with a sale in that time
- Companies
- 2
- Filed as an executive or holder
Companies
- VCELVericel CorpDirector
- ACCELERON PHARMA INCSVP, CFO and Treasurer
Sales by reason
0
Routine
17
Plan not stated
0
No plan
32
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- ACCELERON PHARMA INC487,771 shares
- VCEL70,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- Nov 10, 2026Unusual
Sold 27.7% of their holdings
$413k7,000 shares at $58.96
- Nov 10, 2026Notice
Filed a notice to sell 7,000 shares
$409k7,000 shares
- Aug 12, 2026Unusual
Sold 27.7% of their holdings
$312k7,000 shares at $44.53
- Aug 12, 2026Notice
Filed a notice to sell 7,000 shares
$309k7,000 shares
- May 13, 2026Unusual
Sold 27.7% of their holdings
$230k7,000 shares at $32.83
- May 13, 2026Notice
Filed a notice to sell 7,000 shares
$228k7,000 shares
- Feb 11, 2026Unusual
Sold 31.7% of their holdings
$243k7,000 shares at $34.66
- Feb 11, 2026Notice
Filed a notice to sell 7,000 shares
$249k7,000 shares
- Nov 10, 2025Unusual
Sold 31.7% of their holdings
$270k7,000 shares at $38.59
- Nov 10, 2025Notice
Filed a notice to sell 7,000 shares
$278k7,000 shares
10 of 59
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Nov 12, 2026 | VCEL | Director | Sold | 7,000 | $58.96 | $413k | 18,300 | SEC |
| Nov 10, 2026 | Nov 12, 2026 | VCEL | Director | Exercised or settledStock Option (Right to Buy) | 7,000 | 0 | SEC | ||
| Nov 10, 2026 | Nov 12, 2026 | VCEL | Director | Exercised options | 7,000 | $13.05 | $91k | 25,300 | SEC |
| Aug 12, 2026 | Aug 14, 2026 | VCEL | Director | Sold | 7,000 | $44.53 | $312k | 18,300 | SEC |
| Aug 12, 2026 | Aug 14, 2026 | VCEL | Director | Exercised or settledStock Option (Right to Buy) | 7,000 | 7,000 | SEC | ||
| Aug 12, 2026 | Aug 14, 2026 | VCEL | Director | Exercised options | 7,000 | $13.05 | $91k | 25,300 | SEC |
| May 19, 2026 | May 21, 2026 | IVVD | Director | AwardedStock Option (Right to Buy) | 50,000 | 50,000 | SEC | ||
| May 13, 2026 | May 15, 2026 | VCEL | Director | Sold | 7,000 | $32.83 | $230k | 18,300 | SEC |
| May 13, 2026 | May 15, 2026 | VCEL | Director | Exercised or settledStock Option (Right to Buy) | 7,000 | 14,000 | SEC | ||
| May 13, 2026 | May 15, 2026 | VCEL | Director | Exercised options | 7,000 | $7.84 | $55k | 21,800 | SEC |
| Apr 29, 2026 | May 1, 2026 | VCEL | Director | Exercised or settledRestricted Stock Unit | 3,200 | 0 | SEC | ||
| Apr 29, 2026 | May 1, 2026 | VCEL | Director | Exercised options | 3,200 | 18,300 | SEC | ||
| Apr 29, 2026 | May 1, 2026 | VCEL | Director | AwardedStock Option (Right to Buy) | 11,200 | 3,200 | SEC | ||
| Feb 11, 2026 | Feb 13, 2026 | VCEL | Director | Sold | 7,000 | $34.66 | $243k | 15,100 | SEC |
| Feb 11, 2026 | Feb 13, 2026 | VCEL | Director | Exercised or settledStock Option (Right to Buy) | 7,000 | 3,500 | SEC | ||
| Feb 11, 2026 | Feb 13, 2026 | VCEL | Director | Exercised options | 7,000 | $2.63 | $18k | 22,100 | SEC |
| Nov 19, 2025 | Nov 20, 2025 | IVVD | Director | Bought | 50,000 | $2.50 | $125k | 50,000 | SEC |
| Nov 10, 2025 | Nov 12, 2025 | VCEL | Director | Sold | 7,000 | $38.59 | $270k | 15,100 | SEC |
| Nov 10, 2025 | Nov 12, 2025 | VCEL | Director | Exercised or settledStock Option (Right to Buy) | 7,000 | 10,500 | SEC | ||
| Nov 10, 2025 | Nov 12, 2025 | VCEL | Director | Exercised options | 7,000 | $2.63 | $18k | 22,100 | SEC |
| Aug 6, 2025 | Aug 8, 2025 | VCEL | Director | Sold | 7,000 | $35.92 | $251k | 15,100 | SEC |
| Aug 6, 2025 | Aug 8, 2025 | VCEL | Director | Exercised or settledStock Option (Right to Buy) | 7,000 | 0 | SEC | ||
| Aug 6, 2025 | Aug 8, 2025 | VCEL | Director | Exercised options | 7,000 | $2.76 | $19k | 22,100 | SEC |
| May 20, 2025 | May 22, 2025 | IVVD | Director | AwardedStock Option (Right to Buy) | 50,000 | 50,000 | SEC | ||
| May 7, 2025 | May 9, 2025 | VCEL | Director | Sold | 7,000 | $39.98 | $280k | 15,100 | SEC |
| May 7, 2025 | May 9, 2025 | VCEL | Director | Exercised or settledStock Option (Right to Buy) | 7,000 | 7,000 | SEC | ||
| May 7, 2025 | May 9, 2025 | VCEL | Director | Exercised options | 7,000 | $2.76 | $19k | 22,100 | SEC |
| Apr 30, 2025 | May 2, 2025 | VCEL | Director | Exercised or settledRestricted Stock Unit | 3,200 | 0 | SEC | ||
| Apr 30, 2025 | May 2, 2025 | VCEL | Director | Exercised options | 3,200 | 15,100 | SEC | ||
| Apr 30, 2025 | May 2, 2025 | VCEL | Director | AwardedStock Option (Right to Buy) | 11,200 | 3,200 | SEC | ||
| Feb 12, 2025 | Feb 14, 2025 | VCEL | Director | Sold | 7,000 | $55.46 | $388k | 11,900 | SEC |
| Feb 12, 2025 | Feb 14, 2025 | VCEL | Director | Exercised or settledStock Option (Right to Buy) | 7,000 | 14,000 | SEC | ||
| Feb 12, 2025 | Feb 14, 2025 | VCEL | Director | Exercised options | 7,000 | $3.60 | $25k | 12,900 | SEC |
| Nov 13, 2024 | Nov 15, 2024 | VCEL | Director | Sold | 7,000 | $55.54 | $389k | 11,900 | SEC |
| Nov 13, 2024 | Nov 15, 2024 | VCEL | Director | Exercised or settledStock Option (Right to Buy) | 7,000 | 6,000 | SEC | ||
| Nov 13, 2024 | Nov 15, 2024 | VCEL | Director | Exercised options | 7,000 | $3.74 | $26k | 18,900 | SEC |
| Aug 7, 2024 | Aug 9, 2024 | VCEL | Director | Sold | 7,000 | $45.94 | $322k | 11,900 | SEC |
| Aug 7, 2024 | Aug 9, 2024 | VCEL | Director | Exercised options | 7,000 | $3.74 | $26k | 13,900 | SEC |
| Aug 7, 2024 | Aug 9, 2024 | VCEL | Director | AwardedStock Option (Right to Buy) | 7,000 | 13,000 | SEC | ||
| May 21, 2024 | May 23, 2024 | IVVD | Director | AwardedStock Option (Right to Buy) | 100,000 | 100,000 | SEC | ||
| May 1, 2024 | May 3, 2024 | VCEL | Director | Exercised or settledRestricted Stock Unit | 3,200 | 0 | SEC | ||
| May 1, 2024 | May 3, 2024 | VCEL | Director | Exercised options | 3,200 | 11,900 | SEC | ||
| May 1, 2024 | May 3, 2024 | VCEL | Director | AwardedStock Option (Right to Buy) | 11,200 | 3,200 | SEC | ||
| Sep 25, 2023 | Sep 25, 2023 | Decibel Therapeutics, Inc. | Director | Returned to the companyStock Option (right to buy) | 25,000 | 0 | SEC | ||
| Sep 25, 2023 | Sep 25, 2023 | Decibel Therapeutics, Inc. | Director | Returned to the company | 5,000 | 0 | SEC | ||
| Jun 13, 2023 | Jun 14, 2023 | Decibel Therapeutics, Inc. | Director | AwardedStock Option (right to buy) | 5,000 | 5,000 | SEC | ||
| Jun 13, 2023 | Jun 14, 2023 | Decibel Therapeutics, Inc. | Director | Awarded | 5,000 | 5,000 | SEC | ||
| May 3, 2023 | May 5, 2023 | VCEL | Director | AwardedStock Option (right to buy) | 11,200 | 3,200 | SEC | ||
| Apr 27, 2023 | Apr 28, 2023 | VCEL | Director | Exercised or settledRestricted Stock Unit | 2,600 | 0 | SEC | ||
| Apr 27, 2023 | Apr 28, 2023 | VCEL | Director | Exercised options | 2,600 | 8,700 | SEC |
Page 1
Sales and notices (59)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Nov 12, 2026 | VCEL | Director | Form 4 sale | 7,000 | $413k | 27.7% | Unusual | SEC |
| Nov 10, 2026 | Nov 10, 2026 | VCEL | Director | Form 144 notice | 7,000 | $409k | Notice | SEC | |
| Aug 12, 2026 | Aug 14, 2026 | VCEL | Director | Form 4 sale | 7,000 | $312k | 27.7% | Unusual | SEC |
| Aug 12, 2026 | Aug 12, 2026 | VCEL | Director | Form 144 notice | 7,000 | $309k | Notice | SEC | |
| May 13, 2026 | May 15, 2026 | VCEL | Director | Form 4 sale | 7,000 | $230k | 27.7% | Unusual | SEC |
| May 13, 2026 | May 13, 2026 | VCEL | Director | Form 144 notice | 7,000 | $228k | Notice | SEC | |
| Feb 11, 2026 | Feb 13, 2026 | VCEL | Director | Form 4 sale | 7,000 | $243k | 31.7% | Unusual | SEC |
| Feb 11, 2026 | Feb 11, 2026 | VCEL | Director | Form 144 notice | 7,000 | $249k | Notice | SEC | |
| Nov 10, 2025 | Nov 12, 2025 | VCEL | Director | Form 4 sale | 7,000 | $270k | 31.7% | Unusual | SEC |
| Nov 10, 2025 | Nov 10, 2025 | VCEL | Director | Form 144 notice | 7,000 | $278k | Notice | SEC | |
| Aug 6, 2025 | Aug 8, 2025 | VCEL | Director | Form 4 sale | 7,000 | $251k | 31.7% | Unusual | SEC |
| Aug 6, 2025 | Aug 6, 2025 | VCEL | Director | Form 144 notice | 7,000 | $251k | Notice | SEC | |
| May 7, 2025 | May 9, 2025 | VCEL | Director | Form 4 sale | 7,000 | $280k | 31.7% | Unusual | SEC |
| May 7, 2025 | May 7, 2025 | VCEL | Director | Form 144 notice | 7,000 | $280k | Notice | SEC | |
| Feb 12, 2025 | Feb 14, 2025 | VCEL | Director | Form 4 sale | 7,000 | $388k | 37.0% | Unusual | SEC |
| Feb 12, 2025 | Feb 12, 2025 | VCEL | Director | Form 144 notice | 7,000 | $388k | Notice | SEC | |
| Nov 13, 2024 | Nov 15, 2024 | VCEL | Director | Form 4 sale | 7,000 | $389k | 37.0% | Unusual | SEC |
| Nov 13, 2024 | Nov 13, 2024 | VCEL | Director | Form 144 notice | 7,000 | $389k | Notice | SEC | |
| Aug 7, 2024 | Aug 9, 2024 | VCEL | Director | Form 4 sale | 7,000 | $322k | 37.0% | Unusual | SEC |
| Aug 7, 2024 | Aug 7, 2024 | VCEL | Director | Form 144 notice | 7,000 | $322k | Notice | SEC | |
| Sep 24, 2021 | Sep 24, 2021 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 25,000 | $4M | 70.1% | Unusual | SEC |
| Jan 5, 2021 | Jan 6, 2021 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 4,779 | $589k | 45.1% | Unusual | SEC |
| Dec 14, 2020 | Dec 15, 2020 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 42,528 | $5.5M | 79.1% | Unusual | SEC |
| Dec 11, 2020 | Dec 11, 2020 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 7,472 | $934k | 40.0% | Unusual | SEC |
| Apr 9, 2020 | Apr 10, 2020 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 54,000 | $4.7M | 82.8% | Unusual | SEC |
| Jan 2, 2020 | Jan 3, 2020 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 5,579 | $293k | 53.5% | Unusual | SEC |
| Dec 13, 2019 | Dec 17, 2019 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 11,853 | $596k | 53.2% | Unusual | SEC |
| Sep 10, 2019 | Sep 10, 2019 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 8,000 | $362k | 26.4% | Unusual | SEC |
| Apr 9, 2019 | Apr 11, 2019 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 12,000 | $535k | 28.4% | Unusual | SEC |
| Apr 2, 2019 | Apr 4, 2019 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 648 | $31k | 1.5% | Plan not stated | SEC |
| Jan 2, 2019 | Jan 4, 2019 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 5,712 | $244k | 13.0% | Plan not stated | SEC |
| Aug 30, 2018 | Aug 31, 2018 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 12,500 | $675k | 22.1% | Plan not stated | SEC |
| Jun 29, 2018 | Jul 3, 2018 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 25,000 | $1.2M | 36.3% | Unusual | SEC |
| Apr 3, 2018 | Apr 4, 2018 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 4,000 | $154k | 8.3% | Plan not stated | SEC |
| Jan 4, 2018 | Jan 4, 2018 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 19,000 | $815k | 30.7% | Unusual | SEC |
| Sep 12, 2017 | Sep 14, 2017 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 16,000 | $615k | 24.5% | Plan not stated | SEC |
| Jul 5, 2017 | Jul 7, 2017 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 34,400 | $1.1M | 34.5% | Unusual | SEC |
| Jan 4, 2017 | Jan 6, 2017 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 1,700 | $47k | 2.3% | Plan not stated | SEC |
| Jul 1, 2016 | Jul 6, 2016 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 25,300 | $877k | 30.5% | Unusual | SEC |
| May 23, 2016 | May 25, 2016 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 25,300 | $860k | 27.2% | Unusual | SEC |
| Oct 7, 2015 | Oct 9, 2015 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 7,000 | $171k | 8.0% | Plan not stated | SEC |
| Sep 8, 2015 | Sep 10, 2015 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 6,500 | $196k | 14.0% | Plan not stated | SEC |
| Aug 10, 2015 | Aug 12, 2015 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 6,500 | $185k | 14.0% | Plan not stated | SEC |
| Jul 7, 2015 | Jul 9, 2015 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 7,000 | $208k | 16.7% | Plan not stated | SEC |
| Jun 8, 2015 | Jun 9, 2015 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 6,500 | $211k | 17.8% | Plan not stated | SEC |
| May 11, 2015 | May 13, 2015 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 6,500 | $207k | 20.6% | Plan not stated | SEC |
| Apr 7, 2015 | Apr 8, 2015 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 7,000 | $244k | 21.9% | Plan not stated | SEC |
| Mar 9, 2015 | Mar 10, 2015 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 6,500 | $262k | 20.6% | Plan not stated | SEC |
| Feb 9, 2015 | Feb 11, 2015 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 6,500 | $238k | 20.6% | Plan not stated | SEC |
| Jan 12, 2015 | Jan 13, 2015 | ACCELERON PHARMA INC | SVP, CFO and Treasurer | Form 4 sale | 2,000 | $81k | 7.4% | Plan not stated | SEC |
Showing the first 50